JP2021516225A5 - - Google Patents

Info

Publication number
JP2021516225A5
JP2021516225A5 JP2020543957A JP2020543957A JP2021516225A5 JP 2021516225 A5 JP2021516225 A5 JP 2021516225A5 JP 2020543957 A JP2020543957 A JP 2020543957A JP 2020543957 A JP2020543957 A JP 2020543957A JP 2021516225 A5 JP2021516225 A5 JP 2021516225A5
Authority
JP
Japan
Prior art keywords
compound according
optionally substituted
compound
butyl
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020543957A
Other languages
English (en)
Japanese (ja)
Other versions
JP7408557B2 (ja
JP2021516225A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/020732 external-priority patent/WO2019173327A1/en
Publication of JP2021516225A publication Critical patent/JP2021516225A/ja
Publication of JP2021516225A5 publication Critical patent/JP2021516225A5/ja
Priority to JP2023214175A priority Critical patent/JP7809096B2/ja
Application granted granted Critical
Publication of JP7408557B2 publication Critical patent/JP7408557B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020543957A 2018-03-05 2019-03-05 イミダゾジアゼピンジオン及びその使用方法 Active JP7408557B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023214175A JP7809096B2 (ja) 2018-03-05 2023-12-19 イミダゾジアゼピンジオン及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862638448P 2018-03-05 2018-03-05
US62/638,448 2018-03-05
PCT/US2019/020732 WO2019173327A1 (en) 2018-03-05 2019-03-05 Imidazodiazepinediones and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023214175A Division JP7809096B2 (ja) 2018-03-05 2023-12-19 イミダゾジアゼピンジオン及びその使用方法

Publications (3)

Publication Number Publication Date
JP2021516225A JP2021516225A (ja) 2021-07-01
JP2021516225A5 true JP2021516225A5 (https=) 2022-03-14
JP7408557B2 JP7408557B2 (ja) 2024-01-05

Family

ID=67847465

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020543957A Active JP7408557B2 (ja) 2018-03-05 2019-03-05 イミダゾジアゼピンジオン及びその使用方法
JP2023214175A Active JP7809096B2 (ja) 2018-03-05 2023-12-19 イミダゾジアゼピンジオン及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023214175A Active JP7809096B2 (ja) 2018-03-05 2023-12-19 イミダゾジアゼピンジオン及びその使用方法

Country Status (7)

Country Link
US (2) US11623930B2 (https=)
EP (1) EP3761989A4 (https=)
JP (2) JP7408557B2 (https=)
CN (2) CN118908961A (https=)
AU (2) AU2019231208B2 (https=)
CA (1) CA3093084A1 (https=)
WO (1) WO2019173327A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3093084A1 (en) 2018-03-05 2019-09-12 Goldfinch Bio, Inc. Imidazodiazepinediones and methods of use thereof
JP2022551580A (ja) * 2019-10-04 2022-12-12 ゴールドフィンチ バイオ,インク. 巣状分節性糸球体硬化症および糖尿病性腎症のバイオマーカーに基づく処置
CN115927202A (zh) * 2023-01-10 2023-04-07 北京爱思益普生物科技股份有限公司 一种trpc5突变细胞株及其构建方法和应用
WO2024153028A1 (zh) * 2023-01-20 2024-07-25 深圳晶蛋生物医药科技有限公司 大环类化合物、其药物组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994020460A1 (en) * 1993-03-11 1994-09-15 Smithkline Beecham Corporation Chemical compounds
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
TW201444844A (zh) * 2013-03-14 2014-12-01 Hydra Biosciences Inc 經取代之黃嘌呤及使用其之方法
CN107082782B (zh) 2013-03-15 2020-03-20 海德拉生物科学有限责任公司 取代的黄嘌呤及其使用方法
JP6667092B2 (ja) 2014-08-11 2020-03-18 ハイドラ・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーHydra Biosciences, LLC ピロロ[3,2−d]ピリミジン−2,4(3H,5H)−ジオン誘導体
DK3652176T3 (da) 2017-07-11 2022-01-17 Boehringer Ingelheim Int Substituerede xanthinderivater
CA3093084A1 (en) 2018-03-05 2019-09-12 Goldfinch Bio, Inc. Imidazodiazepinediones and methods of use thereof
EP3917940A1 (en) * 2019-01-30 2021-12-08 Rothamsted Research Ltd Cylodimer of dehydrosalicortin and derivatives thereof isolated from plant of the genus salix for use in cancer therapy

Similar Documents

Publication Publication Date Title
JP2021516225A5 (https=)
JP7157804B2 (ja) Nlrp活性に関連する病態を治療するためのスルホンアミド及びその組成物
JP2007508305A5 (https=)
JP5735986B2 (ja) 新規抗マラリア剤
JP2007507542A5 (https=)
TW200911232A (en) Novel therapeutic compounds
CN115697319A (zh) 三萜系化合物nrf2抑制剂的用途
BG107488A (bg) Нестероидални инхибитори на възпаление
JP2024508794A5 (https=)
CA2540541A1 (en) Alkoxy substituted imidazoquinolines
JP7353683B2 (ja) ヘテロアリールアミドピリジノール誘導体、および自己免疫疾患の予防または処置のための活性成分として同誘導体を含む医薬組成物
HRP20240707T1 (hr) Piridazinoni i postupci primjene istih
JP2023504415A5 (https=)
WO2002002542A1 (fr) Compose annulaire a cinq chainons
JP2021530513A5 (https=)
JP2019501927A5 (https=)
IL287159B2 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
JP2021522262A5 (https=)
US20110281861A1 (en) Thiazopyrimidinones and uses thereof
RU2019114964A (ru) Терапевтические средства и способы их применения
JP2024509760A5 (https=)
JP2022551580A5 (https=)
JP2022507505A5 (https=)
JP2004516295A5 (https=)
ZA200503383B (en) 3,4,-Disubstituted pyrroles and their use in treating inflammatory diseases